期刊文献+

应用化学发光免疫分析法检测HCV抗体与其他方法的比较 被引量:4

To Apply Chemiluminescence Immunoassay for HCV Antibody Detection and Compared it with Other Methods
下载PDF
导出
摘要 目的比较化学发光免疫分析(CLIA)法、酶联免疫吸附试验(ELISA)法、胶体金法检测丙型肝炎病毒(HCV)抗体的效果。方法对80份疑似HCV感染的血清标本,分别采用CLIA法、ELISA法试剂1、试剂2和胶体金法检测。结果 CLIA法、ELISA法(试剂1、试剂2)和胶体金法检测阳性率分别为91.25%、80.63%(试剂182.50%、试剂278.75%)和56.25%。结论 CLIA法检出灵敏度显著高于ELISA法和胶体金法。 Objective To evaluate the results of chemiluminescence immunoassay(CLIA) method,anti-HCV ELISA method and colloidal gold method on detection of hepatitis C virus(HCV).Method We collected 80 of suspected infected HCV serum samples.The sera were detected by CLIA,ELISA reagents ①and ② and colloidal gold reagent.Results The positive rates were respectively 91.25% by CLIA,80.63%(reagents ①82.50%,reagents ②78.75%)by ELISA and 56.25% by colloidal gold method.Conclusion The detection rate of CLIA method was significantly higher than ELISA and colloidal gold assay.
机构地区 解放军第 [
出处 《临床输血与检验》 CAS 2011年第3期200-202,共3页 Journal of Clinical Transfusion and Laboratory Medicine
基金 南京军区医学科技创新重点课题(No.08Z009)资助
关键词 丙型肝炎病毒 化学发光免疫分析法 酶联免疫吸附试验 胶体金法 Hepatitis C virus Chemiluminescence immunoassay Enzyme linked immunosorbent assay Colloidal gold assay
  • 相关文献

参考文献9

二级参考文献43

共引文献134

同被引文献66

  • 1廖远泉.PIVKA-Ⅱ检验诊断肝细胞癌的临床应用(日文译文)[J].临床检验杂志(电子版),2012,1(2):116-118. 被引量:5
  • 2廖远泉.丙型肝炎病毒感染致病机制的研究进展[J].临床检验杂志(电子版),2012,1(4):216-220. 被引量:3
  • 3魏来,管文莉,饶慧瑛,杜绍财,祁自柏,任英蓉.丙型肝炎病毒抗体诊断试剂盒(EIAgen HCV Ab Kit)的可信度分析[J].检验医学,2006,21(B10):2-7. 被引量:3
  • 4Gale Mjr, Foy EM. Evasion of intracellular host defence by hepatitis C virus [ J ]. Nature,2005,436 ( 18 ) :939 - 945.
  • 5Hezode C, Forestier N, Dusheiko G, et al. Telaprevir and peginterferon withoutribavirin for chronic HCV infection [ J ]. N Engl J Med,2009 ,360( 30 ) :1839 - 1850.
  • 6Irshad M, Dhar I, Hepatitis C virus core protein an update on its molecular biology. Cellular functions and clinical implications [J]. Med Princ Pract ,2006 ,15 ( 6 ) :405 -416.
  • 7Moratorio G, Martinez M, Gutierrez MF, et al. Evolution of naturally occurring 5' non-coding region variants of hepatitis C virus in human populations of the South American region [ J ]. Virol J,2007,4( 1 ) :79 -85.
  • 8Alter MJ, Kuhnert WL, Finelli L, et al. Guidelines for laboratory, testing and result reporting of antibody to hepatitis C vints Centers for Disease Control and Prevention [ J ]. MMWR RecommRep ,2003,52 ( RR-3 ) : 1 - 13,15.
  • 9Bowser CS, Kaye J, Leier TU, et al. Prevalence of viral and fnycobacterial co-infections in perinatally HIV-infected children [ J ]. Fetal Pediatr Pathol,2006,25 (6) : 321 - 331.
  • 10Laperche S, Le Marrec N, Simon N, et al. Anew HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection [ J ]. Transfusion, 2003,43 ( 7 ) : 958 - 962.

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部